Artiva Biotherapeutics, Inc. (ARTV) short interest & options flow
NASDAQARTV enters its August 7 earnings event having rallied 11% in one week and 23% in one month, yet a meaningful short position and uniformly bullish analyst coverage frame the debate about whether the clinical data can justify that move. Short sellers have been building through July. Short interest jumped roughly 40% over the past month to 7% of the free float — a level large enough…
ARTV short interest surges 249% in one week to 1.26% of float, highest spike since May began.
- Market cap
- $201M
- Next earnings
- 11 Mar 2027
Key data as of 11 Nov 2026
Latest signals on ARTV
- Short Interest
ARTV short interest surges 249% in one week to 1.26% of float, highest spike since May began.
ARTV news and analysis
RSSNo long-form analysis yet for ARTV. Pulse alerts and the live data picture are available on ORTEX.
Open ARTV on ORTEX →Want the live picture for ARTV?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ARTV — free to start on ORTEX.
Sign up for free →Open ARTV on ORTEX